Skip to content

Sagimet Biosciences Inc.

SGMT · XNAS

CIK 1400118fmd_1BMFX5Z4N86DYKE5PT28192D3HManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2022 to Sep 30, 2026, 19 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading